SEC Form 4 · accession 0000919574-17-002207
Insight Molecular Diagnostics Inc. · IMDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
BROADWOOD PARTNERS, L.P.
10% Owner
BROADWOOD CAPITAL INC
10% Owner
Neal C Bradsher
10% Owner
Period of report
Feb 17, 2017
Accepted (ET)
Feb 22, 2017 · 5:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001642380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF1 | Feb 17, 2017 | X | 425,000 | $3.25 | A | 3,056,680 | D | |
| Common Stock, no par valueF2 | Feb 17, 2017 | X | 0 | $3.25 | A | 3,056,680 | I | Footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common StockF4,F1,F3 | $3.25 | Feb 17, 2017 | X | 425,000 | D | — | Oct 17, 2021 | Common Stock | 425,000 | 1,113,461 | D |
| Warrant to Purchase Common StockF4,F2,F3 | $3.25 | Feb 17, 2017 | X | 0 | D | — | Oct 17, 2021 | Common Stock | 0 | 1,113,461 | I |
| Warrant to Purchase Common StockF5,F1,F3 | $3.25 | Feb 17, 2017 | J | 212,500 | A | — | Feb 17, 2022 | Common Stock | 212,500 | 212,500 | D |
| Warrant to Purchase Common StockF5,F2,F3 | $3.25 | Feb 17, 2017 | J | 0 | A | — | Feb 17, 2022 | Common Stock | 0 | 212,500 | I |
Explanation of responses
- F1These securities are owned by Broadwood Partners, L.P., which is a Reporting Person.
- F2The reported securities are directly owned by Broadwood Partners, L.P. and may be deemed beneficially owned by Broadwood Capital, Inc. as General Partner of Broadwood Partners, L.P. and Neal C. Bradsher as President of Broadwood Capital, Inc. The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- F3These warrants are currently exercisable.
- F4These warrants were purchased as part of a unit, with each unit consisting of one share and one warrant (each warrant entitles the holder to purchase one share), at a price of $3.25 per unit.
- F5In consideration for the early exercise by Broadwood Partners, L.P. of 425,000 warrants on February 17, 2017, Broadwood Partners, L.P. received from the Issuer one new warrant with an exercise price of $3.25 for every two warrants that it exercised.